Answers are grounded in this paper and cite their sources.
A new type of bisquinoline antimalarial, containing the basic side chain of the cinchona alkaloids, has been evaluated. Five bis ethers, from 10,11-dihydrocupreine linked through the 6'-hydroxy group by -(CH2)2n- bridges ( n = 2-5) (series A), and six bis amides, from 8'-amino-10,11-dihydrocinchonidine linked by -CO(CH2)2nCO- bridges ( n = 1-6) (series B), were synthesized and screened against chloroquine-sensitive and -resistant strains and a mefloquine-resistant strain of Plasmodium falciparum in vitro. Two analogues of series B ( n = 4; 5), with a 2-(dibutylamino)-1-hydroxyethyl side chain (series C), were also included. Compounds within series A were generally least active. Among the rest were compounds as active as mefloquine, with diminished cross-resistance to the mefloquine-resistant strain. The most potent (series B, n = 4) was highly active against chloroquine-sensitive, chloroquine-resistant and mefloquine-resistant parasites. In vivo testing, however, showed the compound to be too toxic for further development
No takes yet. Share an insight, caveat, or question.
Cowman et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: